---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-000489"
form_type: "8-K"
ticker: "PHIO"
cik: "0001533040"
company_name: "Phio Pharmaceuticals Corp."
filed_at: "2024-01-26T23:59:59+00:00"
generated_at: "2026-06-06T16:32:43.788345+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Phio Pharmaceuticals receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Received Nasdaq deficiency notice on Jan 24, 2024; stock failed to maintain $1.00 minimum bid for 30 consecutive business days.
- Initial compliance period ends July 22, 2024; can regain by closing at $1.00 or more for 10 consecutive business days.
- No immediate effect on listing or trading; company evaluating options to regain compliance.

## SEC filing metadata
- accession: 0001683168-24-000489
- form_type: 8-K
- ticker: PHIO
- cik: 0001533040
- company_name: Phio Pharmaceuticals Corp.
- filed_at: 2024-01-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533040/000168316824000489/0001683168-24-000489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533040/000168316824000489/phio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-000489
- JSON: https://secwatch.observer/filing/0001683168-24-000489.json
- Plain text: https://secwatch.observer/filing/0001683168-24-000489.txt

## Key facts
- Listing & Compliance Notices
  Phio Pharmaceuticals Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: January 24, 2024, Phio Pharmaceuticals Corp. (the “Company”) received written notice (the “Notification Letter”) from The Nasdaq Capital Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days. The Notice has no immediate effect on the Nasdaq listing or trading of the Company’s common stock The Notification Letter provides an initial 180 calendar day period, or until July 22, 2024, in which to reg
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533040/000168316824000489/0001683168-24-000489-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.